Dystrophin Expression in Muscle Following Gene Transfer with a Fully Deleted ("Gutted") Adenovirus Is Markedly Improved by Trans-Acting Adenoviral Gene Products

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Human Gene Therapy

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303401750476249PMID 11560768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of varying key steps in the non-radioactive in situ hybridization protocol: a quantitative study

  2004cited by this paper
• Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin

  2002cited by this paper
• Experimental and therapeutic approaches to muscular dystrophies

  2002cited by this paper
• Muscle-Specific Overexpression of the Adenovirus Primary Receptor CAR Overcomes Low Efficiency of Gene Transfer to Mature Skeletal Muscle

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Optimization of the helper-dependent adenovirus system for production and potency in vivo.

  2000cited by this paper
• Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.

  2000cited by this paper
• Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene

  2000cited by this paper
• Modulation of Starling Forces and Muscle Fiber Maturity Permits Adenovirus-Mediated Gene Transfer to Adult Dystrophic (mdx) Mice by the Intravascular Route

  2000cited by this paper
• Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral Vector

  2000cited by this paper
• DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.

  2000cited by this paper
• Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.

  2000cited by this paper
• Differential influence of the E4 adenoviral genes on viral and cellular promoters

  2000cited by this paper
• Multiply deleted [E1, polymerase‐, and pTP‐] adenovirus vector persists despite deletion of the preterminal protein

  2000cited by this paper
• DNA Replication of First-Generation Adenovirus Vectors in Tumor Cells

  2000cited by this paper
• DNA from Both High-Capacity and First-Generation Adenoviral Vectors Remains Intact in Skeletal Muscle

  1999cited by this paper
• Persistence of an [E1-, Polymerase-] Adenovirus Vector Despite Transduction of a Neoantigen into Immune-Competent Mice

  1999cited by this paper
• E4ORF3 Requirement for Achieving Long-Term Transgene Expression from the Cytomegalovirus Promoter in Adenovirus Vectors

  1999cited by this paper
• Increased Duration of Transgene Expression in the Lung with Plasmid DNA Vectors Harboring Adenovirus E4 Open Reading Frame 3

  1999cited by this paper
• High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy

  1999cited by this paper
• Adenovirus-Mediated Utrophin Gene Transfer Mitigates the Dystrophic Phenotype of mdx Mouse Muscles

  1999cited by this paper
• Effects of Stuffer DNA on Transgene Expression from Helper-Dependent Adenovirus Vectors

  1999cited by this paper
• Characterization of SYBR Gold nucleic acid gel stain: a dye optimized for use with 300-nm ultraviolet transilluminators.

  1999cited by this paper
• Polylysine Modification of Adenoviral Fiber Protein Enhances Muscle Cell Transduction

  1999cited by this paper
• Regulation of Adenovirus-Mediated Transgene Expression by the Viral E4 Gene Products: Requirement for E4 ORF3

  1999cited by this paper
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• High-Level Dystrophin Expression after Adenovirus-Mediated Dystrophin Minigene Transfer to Skeletal Muscle of Dystrophic Dogs: Prolongation of Expression with Immunosuppression

  1998cited by this paper
• In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

  1998cited by this paper
• Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.

  1998cited by this paper
• An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

  1998cited by this paper
• Combinatorial Blockade of Calcineurin and CD28 Signaling Facilitates Primary and Secondary Therapeutic Gene Transfer by Adenovirus Vectors in Dystrophic (mdx) Mouse Muscles

  1998cited by this paper
• Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

  1998cited by this paper
• Adenoviral gene delivery.

  1997cited by this paper
• Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

  1997cited by this paper
• Sensitivity and reproducibility in adenoviral infectious titer determination

  1997cited by this paper
• Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

  1997cited by this paper
• Effect of the E4 region on the persistence of transgene expression from adenovirus vectors

  1997cited by this paper
• E4 gene function in adenovirus, adenovirus vector and adeno-associated virus infections.

  1997cited by this paper
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

  1997cited by this paper
• Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo

  1997influential reference
• Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.

  1997cited by this paper
• Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo

  1997cited by this paper
• A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging

  1997cited by this paper
• Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA.

  1997cited by this paper
• Gene therapy research for Duchenne and Becker muscular dystrophies.

  1997cited by this paper
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• Dystrophin and Its Isoforms

  1996cited by this paper
• Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy

  1996cited by this paper
• Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

  1996cited by this paper
• Dystrophin Expression in Muscles of mdx Mice After Adenovirus-Mediated In Vivo Gene Transfer

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996cited by this paper
• Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

  1996cited by this paper
• Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene.

  1996cited by this paper
• Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

  1996cited by this paper
• Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

  1996cited by this paper
• Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

  1996cited by this paper
• Multifactional glucanases.

  1996cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996influential reference
• Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

  1996cited by this paper
• Transient Expression of Genes Transferred In Vivo into Heart Using First-Generation Adenoviral Vectors: Role of the Immune Response

  1995cited by this paper
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants.

  1995cited by this paper
• Post-transcriptional control of adenovirus gene expression.

  1995cited by this paper
• A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.

  1995cited by this paper
• [2] Techniques for human adenovirus vector construction and characterization

  1995cited by this paper
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity.

  1994cited by this paper
• Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene

  1993cited by this paper
• Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review.

  1992cited by this paper
• Manipulation of adenovirus vectors.

  1991cited by this paper
• Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

  1991cited by this paper
• Somatic reversion/suppression of the mouse mdx phenotype in vivo.

  1990cited by this paper
• Selective extraction of polyoma DNA from infected mouse cell cultures.

  1967cited by this paper

• George Karpati

  2021cites this paper
• Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy

  2020cites this paper
• Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

  2020cites this paper
• Design of Muscle Gene Therapy Expression Cassette

  2019cites this paper
• Gene Therapy for Inherited Retinal Degeneration

  2019cites this paper
• Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies.

  2019cites this paper
• Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies


  2017cites this paper
• Progress toward Gene Therapy for Duchenne Muscular Dystrophy.

  2017cites this paper
• Gene and splicing therapies for neuromuscular diseases.

  2015cites this paper
• Genetic and Cell-Mediated Therapies for Duchenne Muscular Dystrophy

  2015cites this paper
• Duchenne Muscular Dystrophy Gene Therapy in the Canine Model

  2015cites this paper
• High Throughput Screening in Duchenne Muscular Dystrophy: From Drug Discovery to Functional Genomics

  2014cites this paper
• Abstract 3305: Sustained production of a soluble IGF-I receptor by gutless adenovirus - transduced host cells protects from tumor growth in the liver .

  2013cites this paper
• Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle

  2012cites this paper
• Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors

  2012cites this paper
• Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies

  2012cites this paper
• Efficacy and Site-Specificity of Adenoviral Vector Integration Mediated by the Phage φC31 Integrase

  2012cites this paper
• Genetic Syndromes & Gene Therapy

  2011cites this paper
• Helper-Dependent Adenoviral Vectors.

  2011cites this paper
• Electrotransfer of the Full-Length Dog Dystrophin into Mouse and Dystrophic Dog Muscles

  2010cites this paper
• Modulating Immune Responses in Muscle Gene Therapy

  2010cites this paper
• Effects of manipulating the immune system on dystrophin gene transfer and dystrophic phenotype in striated muscles of Duchenne muscular dystrophy model, mdx mouse

  2010cites this paper
• Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives

  2010cites this paper
• Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunity

  2010cites this paper
• Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy

  2010cites this paper
• Effects of irradiation of adult mdx mice prior to full-length dystrophin cDNA transfer

  2010cites this paper
• Gene therapy in large animal models of muscular dystrophy.

  2009cites this paper
• Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.

  2008cites this paper
• Designing heart performance by gene transfer.

  2008cites this paper
• The potential of antisense oligonucleotides as a therapy for Duchenne muscular dystrophy in human and canine models of the disease

  2007cites this paper
• Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin.

  2007cites this paper
• A gene therapy approach for treating muscle degeneration in neuromuscular disorders using IGF-I splice variants

  2007cites this paper
• Ex vivo modification of cells to induce a muscle-based expression.

  2006cites this paper
• Adenovirus: from foe to friend

  2006cites this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy

  2005cites this paper
• Gene therapy approaches to cardiovascular disease.

  2005cites this paper
• Molecular Cardiology

  2005cites this paper
• Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors.

  2005cites this paper
• Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.

  2005cites this paper
• CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle

  2004cites this paper
• Muscular dystrophy: from pathogenesis to strategy.

  2004cites this paper
• beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery.

  2004cites this paper
• Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.

  2004cites this paper
• Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL

  2004cites this paper
• AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.

  2004cites this paper
• Sustained Improvement of Muscle Function One Year After Full-Length Dystrophin Gene Transfer into mdx Mice by a Gutted Helper-Dependent Adenoviral Vector

  2004cites this paper
• Improved Vascular Gene Transfer With a Helper-Dependent Adenoviral Vector

  2004cites this paper
• Therapeutic strategies for Duchenne and Becker dystrophies.

  2004cites this paper
• Potential genetic therapies for acute lung injury.

  2004cites this paper
• β2 Adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery

  2004cites this paper
• 2 Gene Therapy Approaches to Cardiovascular Disease

  2004cites this paper
• Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.

  2003influential citation
• Dystrophin Delivery in Dystrophin-Deficient DMDmdx Skeletal Muscle by Isogenic Muscle-Derived Stem Cell Transplantation

  2003cites this paper
• Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.

  2003cites this paper
• Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin

  2002cites this paper
• Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses 1

  2002cites this paper
• Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1

  2002cites this paper
• Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter.

  2002cites this paper
• Gene therapy in orthopaedic surgery.

  2002cites this paper
• Experimental and therapeutic approaches to muscular dystrophies

  2002cites this paper
• Gutless adenoviral vectors — Promising tools for gene therapy

  2002cites this paper
• Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector

  2002cites this paper
• Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?

  2002cites this paper
• Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral Vector

  2000cites this paper
• DNA Replication of First-Generation Adenovirus Vectors in Tumor Cells

  2000cites this paper